Concepedia

Discontinuation of nucleos(t)ide analogues is not associated with a higher risk of HBsAg seroreversion after antiviral-induced HBsAg seroclearance: a nationwide multicentre study

Minseok Albert Kim, Seung Up Kim, Dong Hyun Sinn, Jeong Won Jang, Young‐Suk Lim, Sang Hoon Ahn, Jae‐Jun Shim, Yeon Seok Seo, Yang Hyun Baek, Sang Gyune Kim,

Gut · 2020 · 37 citations · 24 references

DOIFull text

Open access

Abstract

The discontinuation of NA was not associated with a higher risk of either HBsAg reversion, serum HBV DNA redetection or HCC development compared with NA continuation among patients who achieved HBsAg seroclearance with NA.

References

24

EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection

Pietro Lampertico, Kosh Agarwal, Thomas Berg et al. · Journal of Hepatology · 2017 · 5.3K citations

, , +5

Bias reduction of maximum likelihood estimates

David Firth · Biometrika · 1993 · 4.2K citations

, , +10

Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance

Norah A. Terrault, Anna S. Lok, Brian J. McMahon et al. · Hepatology · 2018 · 4.1K citations · Full text

AASLD guidelines for the treatment of hepatocellular carcinoma

Julie K. Heimbach, Laura Kulik, Richard S. Finn et al. · Hepatology · 2017 · 4.1K citations · Full text

Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update

Shiv Kumar Sarin, Manoj Kumar, George Lau et al. · Hepatology International · 2015 · 2.5K citations · Full text

, , +16